Datamonitor's OTC Pharmaceuticals in Norway industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of OTC Pharmaceuticals in Norway's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of OTC Pharmaceuticals in Norway
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by both value and volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer and/or brand
Also features market breakdown by distribution channel

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purpose of this report Europe comprises Belgium, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, Ukraine and the United Kingdom.

Executive Summary
Market Overview
- Market Definition
- Research Highlights
- Market Analysis
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
- Summary
- Buyer Power
- Supplier Power
- New Entrants
- Substitutes
- Rivalry
Leading Companies
- Johnson & Johnson
- Novartis Ag
- Glaxosmithkline Plc
Market Distribution
Market Forecasts
- Market Value Forecast
Macroeconomic Indicators
Appendix
- Methodology
- Industry Associations
- Related Datamonitor Research
- Disclaimer
About Datamonitor
- Premium Reports
- Summary Reports
- Datamonitor Consulting
List of Tables
- Table 1: Norway Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Table 2: Norway Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Table 3: Norway Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Table 4: Norway Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Table 5: Johnson & Johnson: Key Facts
- Table 6: Johnson & Johnson: Key Financials ($)
- Table 7: Johnson & Johnson: Key Financial Ratios
- Table 8: Novartis Ag: Key Facts
- Table 9: Novartis Ag: Key Financials ($)
- Table 10: Novartis Ag: Key Financial Ratios
- Table 11: Glaxosmithkline Plc: Key Facts
- Table 12: Glaxosmithkline Plc: Key Financials ($)
- Table 13: Glaxosmithkline Plc: Key Financials (£)
- Table 14: Glaxosmithkline Plc: Key Financial Ratios
- Table 15: Norway Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Table 16: Norway Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
- Table 17: Norway Size of Population (Million), 2005-09
- Table 18: Norway Gdp (Constant 2000 Prices, $ Billion), 2005-09
- Table 19: Norway Gdp (Current Prices, $ Billion), 2005-09
- Table 20: Norway Inflation, 2005-09
- Table 21: Norway Consumer Price Index (Absolute), 2005-09
- Table 22: Norway Exchange Rate, 2005-09
List of Figures
- Figure 1: Norway Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Figure 2: Norway Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Figure 3: Norway Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Figure 4: Norway Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in Norway, 2009
- Figure 11: Johnson & Johnson: Revenues & Profitability
- Figure 12: Johnson & Johnson: Assets & Liabilities
- Figure 13: Novartis Ag: Revenues & Profitability
- Figure 14: Novartis Ag: Assets & Liabilities
- Figure 15: Glaxosmithkline Plc: Revenues & Profitability
- Figure 16: Glaxosmithkline Plc: Assets & Liabilities
- Figure 17: Norway Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Figure 18: Norway Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14

Pharmaceutical Market Research

OTC Pharmaceuticals in Norway